Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.

Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.

Item
http://www.wikidata.org/entity/Q34713799
ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancerRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.Testing for HER2 in Breast Cancer: A Continuing Evolution.HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease.Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.Expression analysis of four long noncoding RNAs in breast cancer.Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study.Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade.Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
P2860

Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.

Item
http://www.wikidata.org/entity/Q34713799
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Even low-level HER2 expression ...... n node-positive breast cancer.
@ast
Even low-level HER2 expression ...... n node-positive breast cancer.
@en
Even low-level HER2 expression ...... n node-positive breast cancer.
@nl
type
label
Even low-level HER2 expression ...... n node-positive breast cancer.
@ast
Even low-level HER2 expression ...... n node-positive breast cancer.
@en
Even low-level HER2 expression ...... n node-positive breast cancer.
@nl
prefLabel
Even low-level HER2 expression ...... n node-positive breast cancer.
@ast
Even low-level HER2 expression ...... n node-positive breast cancer.
@en
Even low-level HER2 expression ...... n node-positive breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Even low-level HER2 expression ...... n node-positive breast cancer.
@en
P2093
P2860
P304
P31
P356
10.1097/PAS.0B013E31819437F9
P407
P433
P478
P50
P577
P5875
P698
P932